SCHEMBL24810470

SCHEMBL24810470

c1ccc(-n2c3ccccc3c3cccc(-c4ccc5c6ccccc6n(-c6ccc(-c7ccc(-c8ccc9oc%10ccccc%10c9c8)cc7)cc6)c5c4)c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
ALOX5 P09917 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PLA2G10 O15496 1/20 0.33
HDAC4 P56524 1/20 0.33
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26788487 1.00 KDM4E (0.39) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL18963189 0.95 KDM4E (0.37) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20706668 0.94 KDM4E (0.37) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20821622 0.94 KDM4E (0.40) KDM4EATML3MBTL1ALOX5SIRT2
SCHEMBL17735768 0.94 KDM4E (0.40) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL21365490 0.93 PLA2G2A (0.40) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20706670 0.93 KDM4E (0.34) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL21365498 0.92 PLA2G2A (0.38) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24810471 0.92 KDM4E (0.41) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL12447593 0.92 KDM4E (0.42) KDM4EATML3MBTL1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885ATM 3436/4885L3MBTL1 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.